Mergen.financeBoston Scientific
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sept | Oct | Nov | Dec | Year |
|---|
| 2026 | ▼ 1.9% | ▼ 17.8% | ▼ 18.3% | ▼ 8.2% | ▼ 16.1% | ▼ 11.7% | ▲ 9.5% | ▲ 3.4% | ▼ 9.6% | ▼ 3.8% | ▲ 9.2% | ▼ 51.9% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ▼ 6.1% |
From our own closes, each month-end against the previous month-end. Colour saturates at ▲ 17.8%; an empty cell means no data, a dash means we declined to derive one.
Fiscal period: FY · 2025-12-31 (10-K) — annual data, not TTM · USD · Source: SEC EDGAR (public domain)
Balance-sheet lines and ratios (assets, equity, ROE, ROA, net margin, debt/equity) open on the paid plans. See the plans